HeroSupport SA
3D-printed personalized breast support for radiotherapy.
VENUS SHELL™ is the first and only 3D-printed immobilization device for breast CE marked that helps to treat breast cancer in prone position, faster (minimum 30%) and more effectively. The model is created for each patient via a patented imaging table, using body images acquired via a surface scanner, modeled via our proprietary software, then 3D-printed for use.
Business model description: Target customers: hospitals and clinics, reached through distributors and industrial partners. The primary market is the US, where prone radiotherapy is more common and VENUS SHELL™ fully reimbursed. Other markets include Europe, Switzerland, and Middle East.

Themes: Tech-enabled Solutions | Health | Circular Economy
Regions/Countries of activity or interest: United States of America, Switzerland, Europe, Middle-East
Organisation HQ: Switzerland
Fundraising Stage: Series A
Business Model: B2B
Fundraising Capital type: Equity, Grant, Debt
The information presented on this page has been provided by the participating organisation. Building Bridges publishes this information for general informational purposes only in connection with Building Bridges 2026. Building Bridges has not independently verified the information and does not endorse, recommend or make any representation regarding any organisation, product, service, strategy, investment opportunity or claim described herein. The participating organisation is responsible for the accuracy, completeness and regulatory compliance of the information it provides.